Jeff Sosman
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 8
- Immunology 12
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 4
- Co-authors
- Elicia PenuelTimothy R. WilsonJeff SettlemanMark MerchantRichard M. NeveYulei WangJing PengYibing Yan
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)Investigational New Drugs (2 papers)European Journal of Cancer (2 papers)Medical Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jeff Sosman
38 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.2k
- Immunology 498
- Cancer Research 278
- Molecular Biology 1.2k
- Genetics 169
Countries citing papers authored by Jeff Sosman
This map shows the geographic impact of Jeff Sosman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Sosman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Sosman more than expected).
Fields of papers citing papers by Jeff Sosman
This network shows the impact of papers produced by Jeff Sosman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Sosman. The network helps show where Jeff Sosman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeff Sosman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2014 | 78 | |
| 3 | Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Hit paper breakdown → | 2012 | 884 |
| 4 | 2012 | 5 | |
| 5 | 2011 | 218 | |
| 6 | 2010 | 1 | |
| 7 | Clinical response to ipilimumab: Effect of systemic corticosteroids used to manage immune-related adverse events (irAEs) | 2010 | 5 |
| 8 | 2010 | 77 | |
| 9 | 2009 | 25 | |
| 10 | 2009 | 26 | |
| 11 | 2004 | 6 | |
| 12 | 2003 | 7 | |
| 13 | 2001 | 14 | |
| 14 | 2000 | 77 | |
| 15 | 1995 | 26 | |
| 16 | 1995 | 4 | |
| 17 | 1994 | 99 | |
| 18 | 1994 | 1 | |
| 19 | 1991 | 12 | |
| 20 | 1989 | 9 |
About Jeff Sosman
Jeff Sosman is a scholar working on Oncology, Immunology, Hematology, Transplantation and Immunology and Allergy, having authored 38 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (8 papers), Melanoma and MAPK Pathways (5 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Renal cell carcinoma treatment (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (498 citations), Cancer Research (278 citations), Molecular Biology (1.2k citations) and Genetics (169 citations). Jeff Sosman has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Elicia Penuel, Timothy R. Wilson, Jeff Settleman, Mark Merchant, Richard M. Neve, Yulei Wang, Jing Peng, Yibing Yan, John G. Moffat and Antoni Ribas. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Investigational New Drugs, European Journal of Cancer and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.